{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T15:37:31Z","timestamp":1794670651445,"version":"4.9.1"},"reference-count":26,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,9]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>During double umbilical cord blood transplant (DUCBT), the winning unit (WU) rejects the losing unit (LU) because of WU T cells directed against the LU mismatched HLA. This immune response might protect against relapse, especially when the patient and LU (PT-LU) share the same mismatch with the WU. To validate this hypothesis, a retrospective Eurocord study, conducted on 383 DUCBTs, focused on posttransplant relapse and HLA mismatches between PT-LU and the WU. A PT-LU HLA-A mismatch shared with the WU was associated with a lower 7-year relapse incidence (16% vs 28%; P = .048). In addition, multiple PT-LU shared HLA mismatches were also associated with a lower relapse risk (7% vs 29%; P = .003). In DUCBT with \u22652 HLA mismatches between patient and WU, the number of HLA mismatches between those did not significantly affect relapse incidence, whereas multiple PT-LU shared HLA mismatches remained associated with a lower relapse risk (7% vs 29%; P = .0038). Finally, considering patients who did not develop either grade 2 to 4 acute graft-versus-host disease or chronic graft-versus-host disease, a PT-LU shared HLA-A mismatch as well as multiple PT-LU HLA mismatches shared with the WU remained associated with a significantly lower 7-year relapse incidence. In multivariate adjusted analyses multiple PT-LU shared HLA mismatches remained associated with a significantly reduced 7-year posttransplant relapse risk. Our analysis indicates that, during DUCBT, PT-LU shared HLA mismatches prime an immune response of the WU against leukemia, reducing the long-term risk of posttransplant relapse, and that DCBT has particular utility in those with high-risk leukemia.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025015938","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T15:12:15Z","timestamp":1746198735000},"page":"4425-4435","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":11,"title":["Impact of shared HLA determinants between patient and losing cord blood unit on relapse after double cord blood transplantation"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6046-8428","authenticated-orcid":false,"given":"Robert","family":"Wynn","sequence":"first","affiliation":[{"name":"1BMT Programme, Royal Manchester Children\u2019s Hospital, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Volt","sequence":"additional","affiliation":[{"name":"2Eurocord, H\u00f4pital Saint Louis Assistance Publique\u2013H\u00f4pitaux de Paris, Institut de Recherche de Saint Louis EA3518, Universit\u00e9 de Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Guardiola","sequence":"additional","affiliation":[{"name":"2Eurocord, H\u00f4pital Saint Louis Assistance Publique\u2013H\u00f4pitaux de Paris, Institut de Recherche de Saint Louis EA3518, Universit\u00e9 de Paris Cit\u00e9, Paris, France"},{"name":"3Department of Histopathology and Molecular Biology, Angers University Hospital, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srividhya","family":"Senthil","sequence":"additional","affiliation":[{"name":"1BMT Programme, Royal Manchester Children\u2019s Hospital, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziana","family":"Scigliuolo","sequence":"additional","affiliation":[{"name":"2Eurocord, H\u00f4pital Saint Louis Assistance Publique\u2013H\u00f4pitaux de Paris, Institut de Recherche de Saint Louis EA3518, Universit\u00e9 de Paris Cit\u00e9, Paris, France"},{"name":"4Monacord, Centre Scientifique de Monaco, Monaco, Monaco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Kenzey","sequence":"additional","affiliation":[{"name":"2Eurocord, H\u00f4pital Saint Louis Assistance Publique\u2013H\u00f4pitaux de Paris, Institut de Recherche de Saint Louis EA3518, Universit\u00e9 de Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Cappelli","sequence":"additional","affiliation":[{"name":"2Eurocord, H\u00f4pital Saint Louis Assistance Publique\u2013H\u00f4pitaux de Paris, Institut de Recherche de Saint Louis EA3518, Universit\u00e9 de Paris Cit\u00e9, Paris, France"},{"name":"4Monacord, Centre Scientifique de Monaco, Monaco, Monaco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Ruggeri","sequence":"additional","affiliation":[{"name":"2Eurocord, H\u00f4pital Saint Louis Assistance Publique\u2013H\u00f4pitaux de Paris, Institut de Recherche de Saint Louis EA3518, Universit\u00e9 de Paris Cit\u00e9, Paris, France"},{"name":"5Hematology and Bone Marrow Transplant Unit, San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryad","family":"Tamouza","sequence":"additional","affiliation":[{"name":"6Univ Paris Est Cr\u00e9teil, INSERM U955, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0094-619X","authenticated-orcid":false,"given":"Vanderson","family":"Rocha","sequence":"additional","affiliation":[{"name":"2Eurocord, H\u00f4pital Saint Louis Assistance Publique\u2013H\u00f4pitaux de Paris, Institut de Recherche de Saint Louis EA3518, Universit\u00e9 de Paris Cit\u00e9, Paris, France"},{"name":"7Service of Hematology, Transfusion and Cell Therapy, and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology, Hospital das Cl\u00ednicas, Faculty of Medicine, S\u00e3o Paulo University, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Anthias","sequence":"additional","affiliation":[{"name":"8Department of Bone Marrow Transplant, Royal Marsden Hospital National Health Service Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis","family":"Peffault de la Tour","sequence":"additional","affiliation":[{"name":"9Department de Hematologie, H\u00f4pital Saint Louis Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Clesham","sequence":"additional","affiliation":[{"name":"10Department of Bone Marrow Transplant, Royal Free and University College Medical School, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5798-8692","authenticated-orcid":false,"given":"Anna","family":"Castleton","sequence":"additional","affiliation":[{"name":"11Department of Bone Marrow Transplant, Christie National Health Service Trust Hospital, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7696-4752","authenticated-orcid":false,"given":"Michel","family":"Schaap","sequence":"additional","affiliation":[{"name":"12Department of Bone Marrow Transplant, Radboud University Medical Centre, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0480-3911","authenticated-orcid":false,"given":"Persis","family":"Amrolia","sequence":"additional","affiliation":[{"name":"13Department of Bone Marrow Transplant, Great Ormond Street Hospital for Children Natoinal Health Service Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0192-3080","authenticated-orcid":false,"given":"Marc","family":"Bierings","sequence":"additional","affiliation":[{"name":"14Department of Bone Marrow Transplant, Princess M\u00e1xima Center, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J.","family":"Cornelissen","sequence":"additional","affiliation":[{"name":"15Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5608-8107","authenticated-orcid":false,"given":"Kay","family":"Poulton","sequence":"additional","affiliation":[{"name":"16Transplantation Laboratory, Manchester National Health Service Foundation Trust, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliane","family":"Gluckman","sequence":"additional","affiliation":[{"name":"2Eurocord, H\u00f4pital Saint Louis Assistance Publique\u2013H\u00f4pitaux de Paris, Institut de Recherche de Saint Louis EA3518, Universit\u00e9 de Paris Cit\u00e9, Paris, France"},{"name":"4Monacord, Centre Scientifique de Monaco, Monaco, Monaco"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"issue":"8","key":"2025090815212775700_bib1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.7326\/0003-4819-120-8-199404150-00004","article-title":"Identical-twin bone marrow transplants for leukemia","volume":"120","author":"Gale","year":"1994","journal-title":"Ann Intern Med"},{"issue":"24","key":"2025090815212775700_bib2","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1056\/NEJMoa1808777","article-title":"Immune escape of relapsed AML cells after allogeneic transplantation","volume":"379","author":"Christopher","year":"2018","journal-title":"N Engl J Med"},{"issue":"5","key":"2025090815212775700_bib3","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1056\/NEJMoa0811036","article-title":"Loss of mismatched HLA in leukemia after stem-cell transplantation","volume":"361","author":"Vago","year":"2009","journal-title":"N Engl J Med"},{"issue":"10","key":"2025090815212775700_bib4","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1056\/NEJMoa1602074","article-title":"Cord-blood transplantation in patients with minimal residual disease","volume":"375","author":"Milano","year":"2016","journal-title":"N Engl J Med"},{"issue":"10","key":"2025090815212775700_bib5","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1182\/bloodadvances.2022009253","article-title":"T-cell replete cord transplants give superior outcomes in high-risk and relapsed\/refractory pediatric myeloid malignancy","volume":"7","author":"Horgan","year":"2023","journal-title":"Blood Adv"},{"issue":"23","key":"2025090815212775700_bib6","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.1182\/bloodadvances.2020003371","article-title":"High progression-free survival after intermediate intensity double unit cord blood transplantation in adults","volume":"4","author":"Barker","year":"2020","journal-title":"Blood Adv"},{"issue":"11","key":"2025090815212775700_bib7","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1038\/s41409-019-0539-8","article-title":"Unit selection for umbilical cord blood transplantation for adults with acute myeloid leukemia in complete remission: a Japanese experience","volume":"54","author":"Yanada","year":"2019","journal-title":"Bone Marrow Transpl"},{"issue":"12","key":"2025090815212775700_bib8","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.bbmt.2020.07.030","article-title":"Guidelines for cord blood unit selection","volume":"26","author":"Politikos","year":"2020","journal-title":"Biol Blood Marrow Transpl"},{"issue":"5","key":"2025090815212775700_bib9","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1182\/blood-2012-08-449108","article-title":"Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia","volume":"121","author":"Scaradavou","year":"2013","journal-title":"Blood"},{"issue":"19","key":"2025090815212775700_bib10","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1182\/blood-2014-03-566216","article-title":"Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice","volume":"124","author":"Purtill","year":"2014","journal-title":"Blood"},{"issue":"17","key":"2025090815212775700_bib11","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1182\/blood-2016-06-718619","article-title":"CD4+ T-cell alloreactivity toward mismatched HLA class II alleles early after double umbilical cord blood transplantation","volume":"128","author":"Lamers","year":"2016","journal-title":"Blood"},{"issue":"18","key":"2025090815212775700_bib12","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1200\/JCO.20.03502","article-title":"National Marrow Donor Program-sponsored multicenter, phase II trial of HLA-mismatched unrelated donor bone marrow transplantation using post-transplant cyclophosphamide","volume":"39","author":"Shaw","year":"2021","journal-title":"J Clin Oncol"},{"issue":"3","key":"2025090815212775700_bib13","doi-asserted-by":"crossref","first-page":"208.e1","DOI":"10.1016\/j.jtct.2022.12.017","article-title":"Three-year outcomes in recipients of mismatched unrelated bone marrow donor transplants using post-transplantation cyclophosphamide: follow-up from a National Marrow Donor Program-sponsored prospective clinical trial","volume":"29","author":"Shaw","year":"2023","journal-title":"Transpl Cell Ther"},{"issue":"1","key":"2025090815212775700_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1182\/blood-2013-05-506253","article-title":"Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy","volume":"123","author":"Eapen","year":"2014","journal-title":"Blood"},{"issue":"7","key":"2025090815212775700_bib15","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1016\/S2352-3026(17)30104-7","article-title":"Allele-level HLA matching for umbilical cord blood transplantation for non-malignant diseases in children: a retrospective analysis","volume":"4","author":"Eapen","year":"2017","journal-title":"Lancet Haematol"},{"issue":"25","key":"2025090815212775700_bib16","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N Engl J Med"},{"issue":"10","key":"2025090815212775700_bib17","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41409-024-02366-4","article-title":"Half a century of healing: celebrating the 50th anniversary of EBMT","volume":"59","author":"Gluckman","year":"2024","journal-title":"Bone Marrow Transpl"},{"issue":"7","key":"2025090815212775700_bib18","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/s41409-018-0369-0","article-title":"Effects of HLA mismatch on cytomegalovirus reactivation in cord blood transplantation","volume":"54","author":"Yokoyama","year":"2019","journal-title":"Bone Marrow Transpl"},{"issue":"13","key":"2025090815212775700_bib19","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1182\/bloodadvances.2022009251","article-title":"Impact of allele-level HLA matching on outcomes after double cord blood transplantation in adults with malignancies","volume":"7","author":"Fatobene","year":"2023","journal-title":"Blood Adv"},{"issue":"8","key":"2025090815212775700_bib20","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.bbmt.2018.02.014","article-title":"Cord blood unit dominance analysis and effect of the winning unit on outcomes after double-unit umbilical cord blood transplantation in adults with acute leukemia: a retrospective study on behalf of Eurocord, the Cord Blood Committee of Cellular Therapy, Immunobiology Working Party, and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation","volume":"24","author":"Tozatto-Maio","year":"2018","journal-title":"Biol Blood Marrow Transpl"},{"issue":"5","key":"2025090815212775700_bib21","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.kint.2024.07.030","article-title":"Transfusion-induced HLA sensitization in wait-list patients and kidney transplant recipients","volume":"106","author":"Willicombe","year":"2024","journal-title":"Kidney Int"},{"issue":"4","key":"2025090815212775700_bib22","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1097\/HS9.0000000000000285","article-title":"Double umbilical cord blood transplantation in high-risk hematological patients: a phase II study focusing on the mechanism of graft predominance","volume":"3","author":"Kalin","year":"2019","journal-title":"Hemasphere"},{"issue":"3","key":"2025090815212775700_bib23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jtct.2025.01.004","article-title":"The association of HLA-E ligand and NKG2 receptor variation with relapse and mortality after haploidentical related donor transplantation","volume":"31","author":"Petersdorf","year":"2025","journal-title":"Transpl Cell Ther"},{"issue":"2","key":"2025090815212775700_bib24","doi-asserted-by":"crossref","first-page":"101560","DOI":"10.1016\/j.beha.2024.101560","article-title":"Is HLA-E with its receptors an immune checkpoint or an antigenic determinant in allo-HCT?","volume":"37","author":"Rohn","year":"2024","journal-title":"Best Pract Res Clin Haematol"},{"issue":"26","key":"2025090815212775700_bib25","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1182\/blood-2016-01-694349","article-title":"Single- vs double-unit cord blood transplantation for children and young adults with acute leukemia or myelodysplastic syndrome","volume":"127","author":"Michel","year":"2016","journal-title":"Blood"},{"issue":"3","key":"2025090815212775700_bib26","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/bjh.18863","article-title":"Granulocyte transfusion during cord blood transplant for relapsed, refractory AML is associated with massive CD8+ T-cell expansion, significant cytokine release syndrome and induction of disease remission","volume":"202","author":"Borrill","year":"2023","journal-title":"Br J Haematol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/17\/4425\/2409124\/blooda_adv-2025-015938-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/17\/4425\/2409124\/blooda_adv-2025-015938-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T19:21:34Z","timestamp":1757359294000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/17\/4425\/537098\/Impact-of-shared-HLA-determinants-between-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":26,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2025,9,9]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025015938","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9,9]]},"published":{"date-parts":[[2025,8,28]]}}}